These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19202965)

  • 1. Osteoporosis screening: mixed messages in primary care.
    Gourlay M
    Am Fam Physician; 2009 Feb; 79(3):189-90. PubMed ID: 19202965
    [No Abstract]   [Full Text] [Related]  

  • 2. [What are the new French recommendations for the treatment of postmenopausal osteoporosis?].
    Blain H
    Rev Med Interne; 2019 May; 40(5):275-277. PubMed ID: 29891260
    [No Abstract]   [Full Text] [Related]  

  • 3. [Practical guidelines for the management of osteoporosis--evidence-based and cost-effective].
    Bartl R
    Dtsch Med Wochenschr; 2007 May; 132(18):995-9. PubMed ID: 17457784
    [No Abstract]   [Full Text] [Related]  

  • 4. Osteoporosis screening of postmenopausal women in the primary care setting: a case-based approach.
    Edwards BJ; Brooks ER; Langman CB
    Gend Med; 2004 Dec; 1(2):70-85. PubMed ID: 16115586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of screening for osteoporosis in postmenopausal Japanese women.
    Nagata-Kobayashi S; Shimbo T; Fukui T
    J Bone Miner Metab; 2002; 20(6):350-7. PubMed ID: 12434163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model-based cost-effectiveness analysis of osteoporosis screening and treatment strategy for postmenopausal Japanese women.
    Yoshimura M; Moriwaki K; Noto S; Takiguchi T
    Osteoporos Int; 2017 Feb; 28(2):643-652. PubMed ID: 27743068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition of osteoporosis since 1997.
    Simon M
    Am J Public Health; 2002 Nov; 92(11):1707. PubMed ID: 12406786
    [No Abstract]   [Full Text] [Related]  

  • 8. Simulation-based cost-utility analysis of population screening-based alendronate use in Switzerland.
    Schwenkglenks M; Lippuner K
    Osteoporos Int; 2007 Nov; 18(11):1481-91. PubMed ID: 17530156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polish guidelines for the diagnosis and management of osteoporosis: a review of 2013 update.
    Głuszko P; Lorenc RS; Karczmarewicz E; Misiorowski W; Jaworski M;
    Pol Arch Med Wewn; 2014; 124(5):255-63. PubMed ID: 24694725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Verification of the indication for densitometry examination in the population of patients referred by the home doctors].
    Nawrot P; Nowakowski A; Kubaszewski L
    Chir Narzadow Ruchu Ortop Pol; 2005; 70(4):279-83. PubMed ID: 16521529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of using clinical risk factors with and without DXA for osteoporosis screening in postmenopausal women.
    Mueller D; Gandjour A
    Value Health; 2009; 12(8):1106-17. PubMed ID: 19706151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoporosis: a short history of AMWA's mission in action.
    McCurdy W; Galindo D
    J Womens Health (Larchmt); 2009; 18(1):19. PubMed ID: 19072726
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of proposals of Belgian Social Security Institute for reimbursement of bone densitometry tests. Toward a cost-effective strategy for osteoporosis screening?
    Ben Sedrine W; Ethgen O; Devogelaer JP; Depresseux G; Kaufman JM; Goemaere S; Reginster JY
    Aging Clin Exp Res; 2004 Oct; 16(5):413-9. PubMed ID: 15636469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to the U.S. Preventive Services Task Force 2002 osteoporosis screening guidelines in academic primary care settings.
    Powell H; O'Connor K; Greenberg D
    J Womens Health (Larchmt); 2012 Jan; 21(1):50-3. PubMed ID: 22150154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence to inform decision makers in Thailand: a cost-effectiveness analysis of screening and treatment strategies for postmenopausal osteoporosis.
    Kingkaew P; Maleewong U; Ngarmukos C; Teerawattananon Y
    Value Health; 2012; 15(1 Suppl):S20-8. PubMed ID: 22265062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 2010 North American Menopause Society position statement: Updates on screening, prevention and management of postmenopausal osteoporosis.
    Schnatz PF
    Conn Med; 2011 Sep; 75(8):485-7. PubMed ID: 21980680
    [No Abstract]   [Full Text] [Related]  

  • 17. Osteoporosis detection: is BMD testing the future?
    Olson AF
    Nurse Pract; 2007 Jun; 32(6):20-7; quiz 28. PubMed ID: 17557021
    [No Abstract]   [Full Text] [Related]  

  • 18. An ongoing six-year innovative osteoporosis disease management program: challenges and success in an IPA physician group environment.
    Woo A; Hittell J; Beardsley C; Noh C; Stoukides CA; Kaul AF
    Dis Manag; 2004; 7(3):216-25. PubMed ID: 15669581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary prevention of osteoporosis: mass screening scenario or prescreening with questionnaires? An economic perspective.
    Richy F; Ethgen O; Bruyere O; Mawet A; Reginster JY
    J Bone Miner Res; 2004 Dec; 19(12):1955-60. PubMed ID: 15537437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seeking clarification of osteoporosis guidelines.
    Sehmer J
    CMAJ; 2004 Oct; 171(9):1022; author reply 1022-3. PubMed ID: 15505246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.